Learn more

CRYSTAL BIOSCIENCE INC

Overview
  • Total Patents
    75
  • GoodIP Patent Rank
    25,073
  • Filing trend
    ⇩ 28.0%
About

CRYSTAL BIOSCIENCE INC has a total of 75 patent applications. It decreased the IP activity by 28.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, agriculture and pharmaceuticals are TRIANNI INC, MURPHY ANDREW J and GENPHARM INT.

Patent filings per year

Chart showing CRYSTAL BIOSCIENCE INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Harriman William Don 65
#2 Leighton Philip A 44
#3 Etches Robert 33
#4 Leighton Phil 9
#5 Collarini Ellen 7
#6 Van De Lavoir Marie-Cecile 6
#7 William Don Harriman 3
#8 Philip A Leighton 3
#9 Robert Etches 3
#10 Izquierdo Shelley 2

Latest patents

Publication Filing date Title
WO2021003075A1 Anti-b7-h3 antibody and methods of use thereof
WO2021003074A1 Anti-cd38 antibody and methods of use thereof
WO2019240999A1 Camelization of a human variable domain by gene conversion
WO2019241001A1 Transgenic chicken with functionally deleted igy ch1 coding sequence
AU2019282671A1 Transgenic animal for producing diversified antibodies that have the same light chain i
KR20210021002A Transgenic chicken making antibodies with long CDR-H3S stabilized by multiple disulfide bridges and diversified by genetic transformation
WO2019240998A1 Production of antibodies by modification of an autonomous heavy chain variable domain by gene conversion
KR20200133339A Transgenic chickens producing human antibodies
AU2017340378A1 Autologous cells for immunization of chickens
BR112018003778A2 transgenic animal for antibody production that has a common light chain
US2015082471A1 Method for culturing avian gonocytes
US2015322168A1 In vivo method for generating diversity in a protein scaffold
AU2012258786A1 Transgenic chicken comprising an inactivated immunoglobulin gene
EP2464220A1 Transgenic animal for production of antibodies having minimal cdrs
WO2009111014A2 Gel microdrop composition and method of using the same